Effects of duration and number of symptoms on vision-related anxiety in patients with Inherited Retinal Diseases
Carregando...
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS INC
Autores
POPOVA, Lilia T. T.
ABUZAITOUN, Rebhi O. O.
ANDREWS, Chris A. A.
MONDUL, Alison M. M.
LACY, Gabrielle D. D.
MUSCH, David C. C.
JAYASUNDERA, K. Thiran
Citação
OPHTHALMIC GENETICS, v.44, n.1, p.11-18, 2023
Resumo
Background: Patients with Inherited Retinal Diseases (IRDs) are at increased risk for vision-related anxiety due to progressive and irreversible vision loss, yet little is known about risk factors for anxiety in these patients. Materials and Methods: This was a single-center, retrospective cross-sectional study at a large academic center. 128 adults with an IRD and without other significant eye conditions were recruited between December 2016 and March 2020. Participants were asked about the duration and number of symptoms they had in the following vision domains: reading, contrast vision, color vision, glare/light sensitivity, night vision, and peripheral vision. The outcomes of interest were the two domains of the Michigan Vision-Related Anxiety Questionnaire (MVAQ), rod- and cone-function related anxiety. We conducted an adjusted analysis to isolate the independent effect of duration and number of symptoms on vision-related anxiety. Results: Of 126 participants had complete data, 62 (49%) were female and 64 (51%) were male, with an average age of 49 years (range: 18-87). Patients with duration of symptoms for greater than 25 years had an adjusted anxiety theta that was one-half standard deviations lower than patients with symptoms for less time. Patients with higher number of symptoms had higher anxiety theta after adjusting for confounding variables (p < 0.0001). Conclusions: The number of symptoms but not the duration of symptoms, is an independent risk factor for vision-related anxiety. Patients with more symptoms are at higher risk for vision-related anxiety. Having symptoms for longer than 25 years may reduce this anxiety.
Palavras-chave
Inherited retinal diseases, vision-related anxiety, anxiety, low-vision, patient-reported outcomes
Referências
- Cumberland PM, 2016, JAMA OPHTHALMOL, V134, P959, DOI 10.1001/jamaophthalmol.2016.1778
- Demmin DL, 2020, CLIN OPHTHALMOL, V14, P4229, DOI 10.2147/OPTH.S258783
- Diniz A, 2016, OPHTHALMOLOGY, V123, P754, DOI 10.1016/j.ophtha.2015.12.014
- Frank CR, 2019, JAMA OPHTHALMOL, V137, P793, DOI 10.1001/jamaophthalmol.2019.1085
- Georgiou M, 2021, CLIN EXP OPHTHALMOL, V49, P270, DOI 10.1111/ceo.13917
- Gill JS, 2019, BRIT J OPHTHALMOL, V103, P711, DOI 10.1136/bjophthalmol-2018-313278
- Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40
- Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7
- Holladay JT, 1997, J REFRACT SURG, V13, P388
- Holloway EE, 2015, AUSTRALAS J AGEING, V34, P229, DOI 10.1111/ajag.12159
- Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004
- Lacy GD, 2021, AM J OPHTHALMOL, V225, P137, DOI 10.1016/j.ajo.2020.12.001
- Lacy GD, 2021, AM J OPHTHALMOL, V222, P60, DOI 10.1016/j.ajo.2020.08.032
- Lacy GD, 2020, OPHTHALMIC GENET, V41, P315, DOI 10.1080/13816810.2020.1776337
- Lam BL, 2008, ARCH OPHTHALMOL-CHIC, V126, P975, DOI 10.1001/archopht.126.7.975
- Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019
- Sainohira M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195983
- Senra H, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-06252-1
- van der Aa HPA, 2016, OPHTHAL PHYSL OPT, V36, P584, DOI 10.1111/opo.12313
- Zahid S, 2014, ADV EXP MED BIOL, V801, P131, DOI 10.1007/978-1-4614-3209-8_17
- Zhang XZ, 2013, JAMA OPHTHALMOL, V131, P573, DOI 10.1001/jamaophthalmol.2013.2597
- Zheng YJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46453